OXYMETAZOLINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Oxymetazoline Hydrochloride, and when can generic versions of Oxymetazoline Hydrochloride launch?
Oxymetazoline Hydrochloride is a drug marketed by Taro and is included in one NDA.
The generic ingredient in OXYMETAZOLINE HYDROCHLORIDE is oxymetazoline hydrochloride. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the oxymetazoline hydrochloride profile page.
Summary for OXYMETAZOLINE HYDROCHLORIDE
Recent Clinical Trials for OXYMETAZOLINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Rigshospitalet, Denmark | Phase 4 |
University of Alabama at Birmingham | Phase 4 |
University of South Florida | Phase 4 |
Pharmacology for OXYMETAZOLINE HYDROCHLORIDE
Drug Class | Vasoconstrictor |
Physiological Effect | Increased Sympathetic Activity Vasoconstriction |
Medical Subject Heading (MeSH) Categories for OXYMETAZOLINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for OXYMETAZOLINE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for OXYMETAZOLINE HYDROCHLORIDE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
RHOFADE | Topical Cream | oxymetazoline hydrochloride | 1% | 208552 | 1 | 2019-06-20 |
US Patents and Regulatory Information for OXYMETAZOLINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Taro | OXYMETAZOLINE HYDROCHLORIDE | oxymetazoline hydrochloride | CREAM;TOPICAL | 213584-001 | Oct 4, 2021 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |